Tg Therapeutics (TGTX) Other Non-Current Assets (2010 - 2026)

Tg Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 3.84% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 3.84% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 57.47% from the prior year.
• Other Non-Current Assets slipped to $1.4 million in Q1 2026 per TGTX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.2 million in Q2 2024 and bottomed at $1.3 million in Q1 2022.
• The 5-year median for Other Non-Current Assets is $1.3 million (2024), against an average of $1.5 million.
• Across the five-year window, Other Non-Current Assets jumped 68.49% in 2024 and slumped 38.93% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then climbed by 0.94% to $1.3 million in 2023, then rose by 1.01% to $1.3 million in 2024, then surged by 57.47% to $2.0 million in 2025, then sank by 33.86% to $1.4 million in 2026.
• Per Business Quant, the three latest TGTX Other Non-Current Assets figures stand at $1.4 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025).